BIO-TECHNE Corp (TECH) company profile

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and analytical services across research, diagnostic, and bioprocessing markets. Operating through its Protein Sciences and Diagnostics and Spatial Biology segments, the company offers specialized proteins, antibodies, small molecules, manual and automated protein analysis tools, spatial genomic assays, and clinical diagnostic controls and calibrators. Its products serve academic and industrial researchers, pharmaceutical and biotechnology companies, contract research organizations, diagnostic developers, and clinical testing laboratories worldwide.

Headquartered in Minneapolis, Minnesota, the company operates globally with offices throughout North America, Europe, and Asia. Bio-Techne employs approximately 3,000 people and manufactures the majority of its portfolio across multiple locations in North America, as well as sites in the United Kingdom, Canada, Switzerland, and China.

Summary of the business section of Bio-Techne's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“Through its subsidiaries, Bio-Techne employed approximately 3,000 full-time and part-time employees as of June 30, 2026, of whom approximately 2,200 were employed in the U.S.”